Two Sigma Securities’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,000
Closed -$233K 2857
2024
Q3
$233K Sell
1,000
-600
-38% -$123K ﹤0.01% 2007
2024
Q2
$323K Sell
1,600
-4,200
-72% -$757K ﹤0.01% 1926
2024
Q1
$994K Sell
5,800
-11,900
-67% -$2.22M 0.01% 1139
2023
Q4
$3.84M Buy
17,700
+10,400
+142% +$1.78M 0.04% 452
2023
Q3
$1.16M Buy
7,300
+6,600
+943% +$1.48M 0.01% 944
2023
Q2
$202K Sell
700
-300
-30% -$91.1K ﹤0.01% 2221
2023
Q1
$319K Buy
+1,000
New +$296K 0.01% 1642

Other funds holding PODD

Two Sigma Securities's PODD Position: Q2 2026 in Review

Two Sigma Securities sold out of Insulet (PODD) in Q2 2026, closing a stake of 1,023 shares — an estimated $215K sold.

Two Sigma Securities first reported a position in PODD in Q2 2021 and held it in 8 quarters. The position peaked at $959K in Q3 2023. 727 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Two Sigma Securities reported no remaining Insulet position as of Q2 2026 after selling out during the quarter.
  • Two Sigma Securities sold 1,023 Insulet shares in Q2 2026, an estimated $215K.
  • Two Sigma Securities first reported a position in Insulet in Q2 2021 and held it in 8 quarters.
  • Two Sigma Securities's Insulet position peaked at $959K in Q3 2023.
  • 727 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.